Kronos Bio

Acquired

Pioneering precision oncology

San Mateo, United States · Founded 2017 · $260.0M raised

Employees
1–10
Founded
2017
Business Model
B2B
Total Funding
$260.0M
Last Round
$155.0M Series BAug 2020
Rounds
2
Acquisition Date
May 2025

About

Kronos Bio is a clinical-stage biopharmaceutical company focused on developing small-molecule therapeutics that target deregulated transcription factors to treat cancer and other diseases.

Summary

Kronos Bio is a Biotech company based in San Mateo, United States, founded in 2017. It has raised $260.0M in total across 2 rounds, most recently a $155.0M Series B round in Aug 2020. Investors include Concentra Biosciences, Perceptive Advisors and Vida Ventures.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

AcquisitionAcquisition by Concentra BiosciencesMay 2025

Sign up to see all 4 rounds

Series A through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Kronos Bio on Indexed.vc
<a href="https://indexed.vc/companies/kronos-bio"><img src="https://indexed.vc/api/badge/company/kronos-bio" alt="Kronos Bio on Indexed.vc" width="260" height="76" /></a>